We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+8.84%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$212B
AUM Growth
+$25.4B
Cap. Flow
+$11.1B
Cap. Flow %
5.24%
Top 10 Hldgs %
35.63%
Holding
5,234
New
558
Increased
1,559
Reduced
2,300
Closed
327

Sector Composition

Rank Sector Weight
1 Technology 13.39%
2 Financials 7.95%
3 Communication Services 5.87%
4 Consumer Discretionary 5.85%
5 Healthcare 5.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UHT
2851
Universal Health Realty Income Trust
UHT
$594M
$714K ﹤0.01%
11,598
-15,612
-57% -$1.06M
ITCI
2852
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$714K ﹤0.01%
17,471
-76,894
-81% -$2.84M
UPLD icon
2853
Upland Software
UPLD
$13.7M
$712K ﹤0.01%
1,729
-731
-30% -$321K
WDC icon
2854
CALL
Western Digital
WDC
$149B
$712K ﹤0.01%
13,230
-3,704
-22% -$200K
ASIX icon
2855
AdvanSix
ASIX
$442M
$709K ﹤0.01%
23,767
-16,433
-41% -$493K
HTBK
2856
DELISTED
Heritage Commerce
HTBK
$704K ﹤0.01%
63,257
-9,510
-13% -$113K
LL
2857
DELISTED
LL Flooring Holdings, Inc.
LL
$702K ﹤0.01%
33,288
-24,417
-42% -$575K
DEM icon
2858
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.97B
$697K ﹤0.01%
+15,254
New +$699K
SMBK icon
2859
SmartFinancial
SMBK
$890M
$697K ﹤0.01%
29,055
-9,902
-25% -$233K
ARNA
2860
DELISTED
Arena Pharmaceuticals Inc
ARNA
$696K ﹤0.01%
10,208
-87,519
-90% -$5.71M
TCRR
2861
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$694K ﹤0.01%
42,235
-6,544
-13% -$132K
RETA
2862
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$693K ﹤0.01%
4,898
-2,959
-38% -$334K
MTLS
2863
Materialise
MTLS
$398M
$692K ﹤0.01%
28,716
+23,416
+442% +$656K
HIE
2864
DELISTED
Miller/Howard High Income Equity Fund
HIE
$689K ﹤0.01%
+62,073
New +$629K
IIF
2865
Morgan Stanley India Investment Fund
IIF
$221M
$688K ﹤0.01%
24,049
+12,657
+111% +$301K
JBHT icon
2866
CALL
JB Hunt Transport Services
JBHT
$25.4B
$684K ﹤0.01%
4,200
JBHT icon
2867
PUT
JB Hunt Transport Services
JBHT
$25.4B
$684K ﹤0.01%
4,200
SPHD icon
2868
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.38B
$683K ﹤0.01%
15,494
-7,361
-32% -$329K
NVEE
2869
DELISTED
NV5 Global
NVEE
$682K ﹤0.01%
28,864
-24,380
-46% -$554K
FLXN
2870
DELISTED
Flexion Therapeutics, Inc.
FLXN
$682K ﹤0.01%
82,829
-20,422
-20% -$174K
PKX icon
2871
POSCO
PKX
$17.4B
$680K ﹤0.01%
8,862
+4,562
+106% +$361K
NIC icon
2872
Nicolet Bankshares
NIC
$3.62B
$675K ﹤0.01%
9,597
-3,873
-29% -$302K
MGM icon
2873
CALL
MGM Resorts International
MGM
$11.2B
$674K ﹤0.01%
15,800
GAP
2874
PUT
The Gap Inc
GAP
$7.38B
$673K ﹤0.01%
20,000
INVX
2875
Innovex International
INVX
$1.98B
$673K ﹤0.01%
19,878
-33,775
-63% -$1.14M

Similar funds

Barclays's Q2 2021 Portfolio in Review

As of Q2 2021, Barclays held 5,234 positions worth $212B, up 14% from $186B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Barclays deployed $11.1B of net new capital in Q2 2021, opening 558 new positions and adding to 1,559 existing holdings. Its largest new stake was Proofpoint, Inc.: 1,241,690 shares worth $216M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B trimmed.

  • Barclays's largest Q2 2021 buy was Proofpoint, Inc.: 1,241,690 shares worth $216M.
  • Barclays added most to iShares US Real Estate ETF in Q2 2021, an estimated $1.48B increase.
  • Barclays's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
  • Barclays fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $466M.
  • Barclays's ten largest holdings make up 36% of its $212B portfolio in Q2 2021.
  • Barclays opened 558 new positions and closed 327 in Q2 2021.
  • Barclays's portfolio value rose 14% quarter-over-quarter to $212B.

Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.